Genetic Technologies
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAGenetic Technologies Limited (GTG) is diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The Company's lead product is BREVAGenplus. In May 2019, the Company announced that it had developed two new cancer risk assessment tests branded as ‘GeneType for Colorectal Cancer' and ‘GeneType for Breast Cancer'
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 785th |  | Genetic Technologies | $10.5m |
| 923rd | | Thorney Opportunities | $2.5m |
| 924th | | DomaCom | $2.5m |
| 926th | | Prescient Therapeutics | $2.4m |
| 927th | | Live Verdure | $2.4m |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 29th | Live Verdure | 227% | |
| 600th | Thorney Opportunities | 5% | 1% |
| 1408th | Prescient Therapeutics | -46% | -4% |
| 1745th | Genetic Technologies | -70% | -30% |
| 1863rd | DomaCom | -83% | -36% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Carl Stubbings, | 03 Nov 2022 |
| NEW ROLE: Kevin Camilleri, | 03 Nov 2022 |
| NEW ROLE: Michael Tonroe, Chief Financial Officer | 16 Feb 2022 |
| NEW ROLE: Chris Saunders, | 24 Nov 2020 |
| NEW ROLE: Diana Newport, | 24 Nov 2020 |
| NEW ROLE: Stanley Sack, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Kevin Fischer, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: Paul Viney, Director | 24 Nov 2020 |
| NEW ROLE: Susan Gross, | 24 Nov 2020 |
